Enrollment Completed for Phase 3 Pyruvate Dehydrogenase Complex Deficiency (PDCD) Clinical Trial
source: unsplash.com

Enrollment Completed for Phase 3 Pyruvate Dehydrogenase Complex Deficiency (PDCD) Clinical Trial

According to a story from PR Newswire, the pharmaceutical company Saol Therapeutics has recently announced that it has completed its enrollment goals for its phase 3 clinical trial. This trial…

Continue Reading Enrollment Completed for Phase 3 Pyruvate Dehydrogenase Complex Deficiency (PDCD) Clinical Trial
In Utero DMD Therapy Was Unsuccessful in Murine Models
Alexas_Fotos / Pixabay

In Utero DMD Therapy Was Unsuccessful in Murine Models

The current standards-of-care for those with Duchenne muscular dystrophy (DMD) include corticosteroids, immunosuppressive treatments, physical therapy, and occupational therapy (among others). Gene therapy has the potential to change the treatment…

Continue Reading In Utero DMD Therapy Was Unsuccessful in Murine Models